Close
CDMO Safety Testing 2026
Novotech

Major pharmaceutical company trusts Tecam technology for emissions removal project in Slovenia

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...
- Advertisement -

Tecam, a leading supplier of environmental technology, announces that it has been awarded a new project for the elimination of Volatile Organic Compounds (VOC) generated at a pharmaceutical production plant in Slovenia.

Under the terms of the agreement, Tecam will supply this pharma company with the design, assembly, installation and commissioning of one Regenerative Thermal Oxidizer (RTO) unit to eliminate exhaust airflow coming from their production processes.

RTO technology solution is getting more and more common in industrial sectors, not only in pharmaceutical production. Moreover, it fully complies with BREF recommendations by the European Commission on emissions abatement.

By eliminating high concentrations of VOCs, RTO technology allows to minimize the concentrations of VOCs emitted into the atmosphere, and at its turn comply with all current and most restrictive regulations at an international level.

“The recent award of this project for VOC emissions removal proves the excellent business relationship between Tecam and this customer. It shows how Tecam can support the pharma industry with eliminating their emissionsโ€ Tecam CEO Bernat Sala declared. โ€œEnvironmental technology has proven to be profitable for companies while allowing them to adapt to the strictest environmental legislation. We are at a decisive moment at an environmental level and must take action nowโ€.

Thanks to the elimination of 99.9% of VOC polluting emissions derived from their pharma production processes, this plant is soon becoming a facility with the highest standards of safety, quality and respect for the environment.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...

Avenda Health Expands Unfold AI Into Midwest Cancer Care

Avenda Health said the University of Michigan Health Weiser...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป